Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration

Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration

The evidence of direct oral anticoagulants (DOACs) usage for venous thromboembolism (VTE) in patients at extremes of body weight or mass index is limited. In such situations, warfarin may be more frequently used. We investigated warfarin time in the therapeutic international normalized ratio range (...

Full description

Bibliographic Details
Main Authors: Natasha Din MBBS MAS, Jun Fan MS, Susan Schmitt PhD, Jennifer D. Guo PhD, Patrick Hlavacek MPH, Krishna Pundi MD, Cristina Russ MD, Birol Emir PhD, Mintu P. Turakhia MD MAS FAHA, Alexander C. Perino MD
Format: Article
Language:English
Published: SAGE Publishing 2023-01-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296231152474

Internet

https://doi.org/10.1177/10760296231152474

Similar Items